Results show that in order to treat patients efficiently, it is necessary to know the specific molecular characteristics of their cancer, such as TGF-β and EGF receptor expression levels
IDIBELL-UB researchers associate changes in white matter connectivity in different subtypes of apathy, one of the most common psychiatric syndromes in Huntington’s disease (HD)
Apathy as an indicator of progression in Huntington’s disease Read More »
This is the main highlight of a study published today in JAMA Internal Medicine, based on a population of about 452,000 people of both genders from 10 European countries followed over a period of 16 years.
Higher consumption of soft drinks linked with an increased risk of mortality Read More »
Digital transformation and online resources are changing the relationship between healthcare professionals and their patients, and the way medical care is provided. The change from a traditional paternalistic model of medical care to a relational one, focused on the needs of patients and their families, promotes the empowerment of the user, responsibility for their illness,
The study describes the ability of a PI3-kinase inhibitor to combat Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva in murine preclinical models
1.- Background The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have launched the Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia – P-CMR[C]. The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative medicine strategies by conducting research
The new study identifies patterns of DNA methylation associated with breast cancer subtypes and response to docetaxel using PDX models
The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual
An inflammatory diet correlates with colorectal cancer risk Read More »
The study has proven the viability of this approach by studying in mice the evolution of metastatic colon tumors of human patients
Scientists Determine a mechanism that would allow treating more aggressive tumors Read More »
The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause
